FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda has given "May Apply" recommendation to Prevest Denpro IPO. Hem Securities has "Neutral" view about the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 1 | 1 | 0 | 0 |
% | 0.00 | 50.00 | 50.00 | 0.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Dilip Davda | May Apply | |
Hem Securities | Neutral |
[Dilip Davda] Based on its super earning in a pandemic IPO pricing appears reasonable, but also raises eyebrows for such earnings as the world economy came to standstill for few months in FY21. The sustainability of higher margins going forward raises concern. Compare with an MNC with no match appears an eyewash for investors to lure them for the investment. Risk seeker/cash surplus investors may consider an investment. Read detail review...
Post Recommendation Manage Recommendations
Note:
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|